Articles tagged "Post-operative complications"

2017 American Transplant Congress
Share35: Increasing Biliary Complications and Healthcare Resources?
J. Fleming,¹ C. Perez,¹ M. Sobhanian,¹ D. Taber,² G. Chedister,² D. Axelrod,³ K. Chavin.²
¹Pharmacy, Medical University of South Carolina, Charleston, SC; ²Surgery, Medical University of South Carolina, Charleston, SC; ³Surgery, East Carolina University, Greenville, NC
Data has shown that major outcomes of liver transplant post-Share35 have been equivalent to pre-Share35, despite organs accumulating longer CIT and traveling further.The PURPOSE of…
2017 American Transplant Congress
De-Novo Portal Vein Thrombosis After Adult-to-Adult Living Donor Liver Transplantation (LDLT) Does Not Impact on Long-Term Outcome.
I. Linares,¹ N. Goldaracena,¹ R. Rosales,¹ L. De La Maza,¹ J. Echeverri,¹ M. Kaths,¹ D. Kollman,¹ N. Selzner,² S. McCluskey,³ G. Sapisochin,¹ L. Lilly,² P. Greig,¹ M. Bhat,² A. Ghanekar,¹ M. Cattral,¹ I. McGilvray,¹ D. Grant,¹ M. Selzner.¹
¹Department of Surgery, Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada; ²Department of Medicine, Multi-Organ Transplant Program, Toronto General Hospital University Health Network, Toronto, ON, Canada; ³Department of Anesthesiology, Toronto General Hospital, University Health Network, Toronto, ON, Canada
Portal vein thrombosis(PVT) after deceased donation has been widely described as a liver transplant complication that can lead to graft failure, high morbidity and mortality.…
2017 American Transplant Congress
Intensive Care Unit Enhanced Recovery Pathway for Liver Transplant Recipients: A Prospective, Observational Study.
C. Kensinger, A. King, S. Karp, P. Pandharipande, K. Wright, L. Weavind.
Vanderbilt University Medical Center, Nashville
Purpose: Surgical clinical pathways have been shown to be effective for enhanced recovery and cost reductions, yet have not be tested in liver transplant (LT)…
2017 American Transplant Congress
Recovery from Hypophosphatemia as a Predictor of Post-Operative Morbidity in Live Donor Hepatectomy.
O. Serrano,¹ D. Berglund,¹ V. Goduguchinta,¹ A. Reddy,¹ J. Menk,² D. Vock,³ V. Kirchner,¹ R. Kandaswamy,¹ A. Matas,¹ T. Pruett,¹ S. Chinnakotla.¹
¹Surgery, University of Minnesota, Minneapolis, MN; ²Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, Minneapolis, MN; ³Biostatistics, School of Public Health, Minneapolis, MN
OBJECTIVE: Live donor hepatectomy (LDH) is associated with significant post-operative hypophosphatemia (POH), which is associated with liver regeneration. We investigated whether the rate of recovery…
2017 American Transplant Congress
High Mortality in Transplant Recipients Associated with Coccidioidomycosis Derived from Organ Donors.
N. Jeyakumar,² N. Neidlinger,³ M. Salvatore,³ C. Brown,⁴ T. Carpenter,³ M. Fung,¹ P. Chin-Hong.¹
¹Department of Medicine, University of California, San Francisco, San Francisco, CA; ²Department of Medicine, University of Miami Miller School of Medicine, Miami, FL; ³Donor Network West, San Ramon, CA; ⁴Decision Patterns, Oakland, CA
Purpose Coccidioidomycosis (CI) occurs in 4-9% of solid organ recipients in endemic areas, resulting in 30-63% mortality. CI can be transmitted directly via transplantation, but…
2017 American Transplant Congress
Incidence and Outcomes of Re-Explorations in Living Donor Liver Transplantation.
V. Varma, S. Sable, S. Kapoor, A. Chauhan, V. Kumaran.
Hepato-Biliary-Pancreatic Surgery and Liver Transplantation, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, Maharashtra, India
Introduction: Re-exploration in Living Donor Liver Transplantation(LDLT) is required in patients for various causes, bleeding being the commonest cause. The outcome of these patients is…
2017 American Transplant Congress
Living Kidney Donor Pharmaceutical Care Needs Identified Through Linked Transplant Registry and Pharmacy Claims Data.
K. Lentine,¹ S. Gustafson,² M. Schnitzler,¹ G. Hess,³ D. Segev,⁴ A. Garg,⁵ N. Lam,⁶ D. Axelrod,⁷ D. Brennan,⁸ H. Randall,¹ B. Kasiske.⁹
¹St Louis Univ, St Louis, MO; ²SRTR, Minneapolis, MN; ³Symphony Health, Philadelphia, PA; ⁴Johns Hopkins, Baltimore, MD; ⁵Western Univ, London, Canada; ⁶Univ Alberta, Edmonton, AB, Canada; ⁷E Carolina Univ, Greenville, NC; ⁸Washington Univ, St. Louis, MO
Limited data are available on pharmaceutical care needs of living kidney donors (LKD).We integrated 1) national US Scientific Registry of Transplant Recipients data for LKD…
2017 American Transplant Congress
Are Drains Required After Donor Hepatectomy?
S. Sharma, S. Kumar, K. Yadav, S. Sable, A. Chauhan, S. Kapoor, V. Varma, V. Kumaran.
Liver Transplant & HPB Surgery Department, Kokilaben Dhirubhai Ambani Hospital, Mumbai, Maharashtra, India
Abdominal drainage after donor hepatectomy is a routine practice in most of the LDLT centres. But the routine abdominal drainage after donor hepatectomy is questioned…
2017 American Transplant Congress
Intraabdominal Infections (IAI) and Bloodstream Infections in Small Intestinal and Multivisceral Transplants (IMVTX).
A. Spence,¹ S. Fogleman,¹ G. Raffaele,² C. Matsumoto,² P. Kumar,¹ R. Biswas,¹ T. Fishbein,² J. Timpone.¹
¹Division of Infectious Diseases, Medstar Georgetown University Hospital, Washington, DC; ²Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington
BackgroundIMVTX is a treatment option for patients with intestinal failure. IMVTX is often complicated by infection in the post-transplant period with the abdomen and bloodstream…
2017 American Transplant Congress
Felodipine Diminishes Decline in Glomerular Filtration Rate in Lung Transplanted Patients Treated with Cyclosporine: A Randomized Placebo Controlled Trial.
M. Hornum,¹ M. Iversen,² P. Oturai,³ M. Andersen,² M. Zemtsovski,⁴ P. Bredahl,⁴ N. Bjarnason,² K. Christiansen,⁵ J. Carlsen,² C. Møller,⁶ B. Feldt-Rasmussen,¹ M. Perch.²
¹Nephrology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; ²Cardiology, Section for Lung Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; ³Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; ⁴Cardiothoracic Anaesthesiology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; ⁵Public Health, Section of Biostatics, University of Copenhagen, Copenhagen, Denmark; ⁶Cardiothoracic Surgery, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Background. Calcium channel blockers may ameliorate the decline in renal function caused by calcineurin inhibitors in lung transplant (LTX) recipients. We previously demonstrated a 47…